CHINA RESOURCES SANJIU MEDICAL & PHARMACEUTICAL CO., LTD. China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Stock
Equities
000999
CNE0000011K8
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 60.84 CNY | -0.26% |
|
+0.08% | +22.34% |
| Sales 2024 * | 27.72B 3.83B | Sales 2025 * | 31.09B 4.29B | Capitalization | 60.12B 8.3B |
|---|---|---|---|---|---|
| Net income 2024 * | 3.38B 467M | Net income 2025 * | 3.85B 531M | EV / Sales 2024 * | 2.03 x |
| Net cash position 2024 * | 3.8B 525M | Net cash position 2025 * | 6.15B 849M | EV / Sales 2025 * | 1.74 x |
| P/E ratio 2024 * |
17.7
x | P/E ratio 2025 * |
15.5
x | Employees | 20,318 |
| Yield 2024 * |
3.05% | Yield 2025 * |
3.29% | Free-Float | 36.6% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.26% | ||
| 1 week | +0.08% | ||
| 1 month | +1.45% | ||
| 3 months | +10.66% | ||
| 6 months | +25.24% | ||
| Current year | +22.34% |
1 week
60.50
63.59
1 month
58.8764.66
Current year
48.1264.66
1 year
40.5264.88
3 years
23.3468.96
5 years
23.3468.96
10 years
17.9968.96
| Managers | Title | Age | Since |
|---|---|---|---|
Hua Wei Qiu
CEO | Chief Executive Officer | 57 | 07-12-26 |
Zheng Liang
DFI | Director of Finance/CFO | 46 | 19-10-28 |
Ji Hong Zhang
CMP | Compliance Officer | 53 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Fang Xu
BRD | Director/Board Member | 61 | 18-04-22 |
Hua Wei Qiu
CEO | Chief Executive Officer | 57 | 07-12-26 |
Ying Tan
PRN | Corporate Officer/Principal | 61 | 05-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.83% | 2 M€ | -18.79% | - | |
| 0.69% | 2 M€ | -14.14% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-31 | 60.84 | -0.26% | 3,220,742 |
| 24-05-30 | 61 | -1.83% | 3,293,951 |
| 24-05-29 | 62.14 | -1.11% | 3,297,912 |
| 24-05-28 | 62.84 | +0.19% | 4,224,743 |
| 24-05-27 | 62.72 | +3.17% | 6,172,439 |
End-of-day quote Shenzhen S.E., May 30, 2024
More quotes
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. specializes in the development, manufacturing and marketing of pharmaceutical products. The group proposes primarily prescribed drugs, OTC drugs and generic drugs.
Sector
Pharmaceuticals
Calendar
2024-08-21
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
60.84
CNY
Average target price
71.73
CNY
Spread / Average Target
+17.90%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +22.34% | 8.3B | |
| +40.73% | 739B | |
| +32.83% | 598B | |
| -6.30% | 353B | |
| +15.15% | 318B | |
| +4.05% | 285B | |
| +15.00% | 240B | |
| -5.52% | 206B | |
| +6.17% | 164B | |
| -0.45% | 162B |
- Stock Market
- Equities
- 000999 Stock
